• SENSEX 73,709.69
    -143.21 (--0.19%)
  • BANKNIFTY 54,976.90
    -511.20 (--0.92%)
  • Max Healthcare
    811.50 811.50(%)
  • L&T Technology
    4,140.50 4,746.95(%)
  • Bajaj Finance
    919.00 788.40(%)
  • NSE
    1,705.00 1,705.00(%)
  • Reliance Industries
    1,234.60 1,611.20(%)
  • TCS
    2,533.10 3,336.70(%)
  • PC Jeweller
    19.14 19.14(%)
  • Cupid
    343.65 369.70(%)
  • HD Fire Protect
    338.00 338.00(%)
  • Infosys
    1,171.00 1,727.85(%)
  • ZF Commercial
    2,073.00 2,053.38(%)
  • Aditya Infotech
    3,879.70 1,301.10(%)
  • HDFC Bank
    698.35 682.00(%)
  • Fractal Analyt.
    828.00 1,119.60(%)
  • SS Retail
    724.90 888.00(%)
  • ICICI Bank
    1,409.50 1,479.90(%)
  • APL Apollo Tubes
    2,052.10 1,691.05(%)
  • Sun Pharma.Inds.
    1,721.70 1,583.60(%)
  • Netweb Technol.
    4,575.95 2,942.45(%)
  • CreditAcc. Gram.
    1,129.35 1,112.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Smruthi Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 5758.0
  • ISIN : INE172E01011
132.35 -10 (-6.76%)
  • As on 21 Oct 2026 (EOD)

  • Today’s Low

    130.50

  • Today’s High

    144.00

  • Open

    141.00

  • Perv Close

    141.95

  • 52W Low

    95.00

  • 52W High

    175.30

Key Indicators

  • P/E(TTM)

    19.13

  • Mar.Cap (₹Cr.)

    151.49

  • Div & Yield %

    1.13

  • Book Value(₹)

    64.22

  • Debt-Equity Ratio

    -6.76

  • AGM Date

    21-Oct-2026

  • EPS

    6.92

  • P/E Ratio

    19.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    151.49

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.45

  • BV (₹)

    64.20

  • Sales( ₹ in Cr.)

    101.97

  • NP (in Cr.)

    3.75

  • NP Var(%)

    5.0

  • Div%

    15.0

  • CPS (₹)

    8.80

  • EPS (₹)

    3.30

  • Traded Value (₹ in Lakhs)

    151.49

  • 52 Week High

    175.30

  • 52 Week Low

    95.00

  • Price BSE

    132.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    151.49

  • P/C Ratio

    15.00

  • P/E Ratio

    40.30

  • Price Vs.BV

    3.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 101.97 126.01 127.64 141.04 133.37 126.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 101.97 126.01 127.64 141.04 133.37 126.50
Other Income 0.12 0.09 0.08 0.11 0.58 0.56
Stock Adjustments -0.10 -0.61 2.66 4.42 2.08 -2.78
Total Income 101.99 125.49 130.38 145.57 136.03 124.28
EXPENDITURE :            
Raw Materials 45.25 68.00 75.01 95.89 82.14 63.68
Power and Fuel Cost 10.08 11.55 10.03 9.43 8.80 8.86
Employee Cost 17.56 17.35 17.16 15.82 13.73 15.64
Other Manufacturing Expenses 8.41 8.29 2.55 2.27 2.10 1.87
Selling and Administration Expenses 4.91 6.23 5.99 4.65 3.62 2.86
Miscellaneous Expenses 3.08 1.80 7.60 7.60 6.63 2.27
Employee Benefit Expenses 17.56 17.35 17.16 15.82 13.73 15.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 89.29 113.22 118.34 135.67 117.02 95.19
Operating Profit 12.69 12.27 12.03 9.89 19.01 29.09
Interest 1.68 1.87 1.41 0.82 0.98 1.09
Gross Profit 11.01 10.40 10.62 9.07 18.03 28.00
Depreciation 6.35 5.50 5.65 4.57 4.26 3.95
Profit Before Tax 4.66 4.90 4.97 4.50 13.77 24.05
Current Tax 1.44 1.37 1.61 1.46 3.56 6.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 -0.03 -0.23 -1.10 -0.17 0.14
Reported Net Profit 3.43 3.56 3.59 4.13 10.38 17.11
Extraordinary Items -0.32 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.75 3.56 3.59 4.13 10.38 17.11
Adjustment below Net Profit 0.00 0.00 0.00 0.30 -0.28 0.92
P & L Balance brought forward 58.32 56.48 55.18 54.48 47.81 33.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.72 1.72 2.29 3.43 3.43 3.43
P & L Balance carried down 60.03 58.32 56.48 55.48 54.48 47.81
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 15.00 15.00 20.00 30.00 30.00
Dividend Per Share(Rs) 1.50 1.50 1.50 2.00 3.00 3.00
Earnings Per Share-Unit Curr 2.99 3.11 3.14 3.61 9.07 14.95
Earnings Per Share(Adj)-Unit Curr 2.99 3.11 3.14 3.61 9.07 14.95
Book Value 64.22 62.58 60.82 59.54 58.68 52.85
Book Value(Adj)-Unit Curr 64.22 62.58 60.82 59.54 58.68 52.85

Shareholding Pattern

  • Promoter Group

    64.73%

  • Public Share Holding

    35.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 246,000 2.15 246,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 7,162,902 62.58 7,162,902 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,408,902 64.73 7,408,902 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 418,939 3.66 182,839 32
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 135,456 1.18 63,456 111
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 103,995 0.91 103,995 143
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 725,153 6.34 725,153 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,547,588 22.26 2,360,888 5,376
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 106,257 0.93 106,257 1
Sub Total 4,037,388 35.27 3,542,588 5,680
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,446,290 100.00 10,951,490 5,686

Company Background

Smruthi Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Smruthi Organics Ltd
  • BSE Code : 5758.0
  • ISIN : INE172E01011

  • Incorporation Year

    1989

  • Registered Office

    165-A Balaji Bhavan 1st Floor
    Railway Lines, Solapur,
    Maharashtra-413001

  • Telephone

    91-217-2310267/2310268

  • FAX

    91-217-2310268

  • Chairman

    E Purushotham

  • Managing Director

    E Purushotham

  • Company Secretary

    Urvashi D Khanna

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Smruthi Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Smruthi Organic 132.35 102.09 101.97 20.49 7.45
Abbott India 25,744.40 7,217.19 6,929.05 33.88 43.78
Astrazeneca Phar 6,076.90 2,304.07 2,275.58 89.56 27.86
Glaxosmi. Pharma 2,463.75 3,932.76 3,790.20 39.36 58.17
Novartis India 1,768.90 393.10 354.33 44.67 15.94
Cipla 1,313.80 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 609.80 773.53 729.81 56.67 12.51
Amrutanjan Healt 495.10 520.13 502.55 26.52 24.16
Fermenta Biotec. 465.60 474.15 450.25 21.74 18.77
Guj. Themis Bio. 351.30 168.25 165.82 93.93 18.05
Ambalal Sarabhai 36.94 19.52 3.94 68.41 6.77